Overseeing the accuracy, timeliness and comprehensiveness of Beacon, Hanson Wade's sector-standard drug development database, establishing and tracking standards for data ingest, processing and validation.

Managing strategic direction and growth opportunities for Beacon, Hanson Wade's highly regarded database of targeted therapies and clinical trials.

Implementing and managing new content opportunities for Beacon, Hanson Wade's unique database of targeted cancer therapies.

Manager of drug pipeline content and policy for Clarivate Analytics' flagship life science solution, Cortellis. Responsible for a team delivering timely and accurate daily data relating to pharmaceutical R&D to thousands of subscribers. Also ensuring content dynamically reflected key developments in this rapidly evolving, cutting-edge field.

Manager/owner of drug pipeline content and policy for the flagship Thomson Reuters competitor intelligence platform, Thomson Pharma, which was renamed and expanded in 2014 as Cortellis, Remained in position following acquisition of Thomson Reuters' life science assets by Clarivate Analytics in October 2016.

Manager/owner of drug pipeline content and policy for the drug pipeline database IDdb (Investigational Drugs Database), later relaunched as Thomson Pharma following the acquisition of the company by Thomson Reuters in August 2002.

Various commissioning roles for a suite of Current Opinion journals, rising to a team leader position.